|
S. W. Lee, Y. H. Park, B. Y. Ryoo, J. C. Lee, C. H. Kim, H. T. Kim |
|
(The efficacy of ZD1839 (Iressa) in patients with advanced non-small cell Lung cancer (NSCLC) who have progressed after previous chemotherapy) |
S. W. Lee, Y. H. Park, B. Y. Ryoo, J. C. Lee, C. H. Kim, H. T. Kim |
|
|
|
|